Microvascular research
Cure8 research brief
Why This Matters
Patients and clinicians are often looking for objective, noninvasive ways to monitor IBD activity. This study suggests a simple nailfold capillary measure may reflect disease activity and add information to CRP, which could help identify active inflammation without invasive testing if validated.
Who Should Pay Attention
Clinicians managing IBD, researchers in IBD biomarkers and microvascular biology, and adult patients interested in noninvasive monitoring approaches.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This single-center prospective case-control study measured nailfold capillary density by capillaroscopy in 85 adults with IBD (73 active, 12 remission) and 41 healthy controls.
Lower capillary density and more dilated/tortuous capillaries were seen in active disease versus remission and controls, and density correlated with CRP, ESR, Mayo score, and CDAI category. The authors report that adding capillary density to CRP improved discrimination for active disease (CRP-density model AUC ~0.94).
The study suggests nailfold capillaroscopy captures a microvascular signal linked to systemic inflammation and clinical activity in IBD and might provide complementary information to CRP. However, this was a single-center study with a small remission subgroup, so findings need replication before clinical use.
Practical points: nailfold capillaroscopy is noninvasive but not yet a routine IBD test; interpretation requires standardized imaging and trained readers. The reported improvement over CRP is promising but preliminary.
Keep In Mind
Structured-content depth: abstract. Findings come from a single-center cohort with a small remission group; this is preliminary and not practice-changing. The study reports associations and diagnostic discrimination but does not establish clinical outcome benefits or guideline-level evidence.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationMicrovascular research
AuthorsAdem Caglayan, Mustafa Comoglu, Emra Asfuroglu Kalkan +4 more
InstitutionAnkara Bilkent City Hospital, Department of Internal Medicine, Ankara, Türkiye. Electronic address: bilkentmedicine@gmail.com.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 6, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Evaluation of serum human galectin 3 as a marker of activity in inflammatory bowel disease in comparison to fecal calprotectin.
Noninvasive blood biomarkers that track IBD activity could reduce reliance on repeat endoscopy. If validated, serum galectin‑3 might complement fecal calprotectin and CRP to help identify active disease.
Association of serological markers with endoscopic mucosal healing and disease activity in patients with inflammatory bowel disease: a retrospective study
Blood markers that correlate with endoscopic healing could help track inflammation noninvasively and may reduce the frequency of endoscopy if validated. For people with IBD, better blood-based tools could make monitoring...
The role of blood lymphocyte levels in evaluating endoscopic remission of inflammatory bowel disease
A simple blood lymphocyte percentage could be a convenient, non-invasive marker to help distinguish endoscopic remission from active disease in both Crohn’s and ulcerative colitis; chemokines CXCL10 and CCL25 may also...